Mochida enters biosimilars fray with Richter alliance
This article was originally published in Scrip
Executive Summary
Mochida Pharmaceutical has taken a decisive plunge into the biosimilars business through a tie-up that provides it with comprehensive access to Gedeon Richter's emerging portfolio in this segment.